Literature DB >> 22778308

Neonatal morbidities and developmental delay in moderately preterm-born children.

Jorien M Kerstjens1, Inger F Bocca-Tjeertes, Andrea F de Winter, Sijmen A Reijneveld, Arend F Bos.   

Abstract

BACKGROUND AND
OBJECTIVE: Children born moderately preterm (32-35(6/7) weeks' gestation) are at increased risk of both neonatal morbidities and developmental delays in early childhood. It is unknown whether neonatal morbidities contribute to the increased risk of developmental delay. The objective of this study was to determine the effect of neonatal morbidities after moderately preterm birth on development at preschool age.
METHODS: In a community-based, stratified cohort, parents of 832 moderately preterm children born in 2002 or 2003 completed the Ages and Stage Questionnaire when their child was 43 to 49 months old. Data on Apgar scores, asphyxia, tertiary NICU admission, hospital transfer, circulatory insufficiency, hypoglycemia, septicemia, mechanical ventilation, continuous positive airway pressure, apneas, caffeine treatment, and hyperbilirubinemia were obtained from medical records. We assessed associations of neonatal characteristics with developmental delay, adjusted for gender, small-for-gestational-age status, gestational age, and maternal education.
RESULTS: Hypoglycemia and asphyxia were associated with developmental delay; odds ratios (ORs) were 2.42 (95% confidence interval [CI]: 1.23-4.77) and 3.18 (95% CI: 1.01-10.0), respectively. Tertiary NICU admission and hyperbilirubinemia had positive but statistically borderline nonsignificant associations with developmental delay: ORs were 1.74 (95% CI: 0.96-3.15) and 1.52 (95% CI: 0.94-2.46), respectively. No other neonatal morbidities were associated with developmental delay. In multivariate analyses, only hypoglycemia was associated with developmental delay (OR: 2.19; 95% CI: 1.08-4.46).
CONCLUSIONS: In moderately preterm-born children, only hypoglycemia increased the risk of developmental delay at preschool age. A concerted effort to prevent hypoglycemia might enhance developmental outcome in this group.

Entities:  

Mesh:

Year:  2012        PMID: 22778308     DOI: 10.1542/peds.2012-0079

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  42 in total

Review 1.  Hypoglycemia in the preterm neonate: etiopathogenesis, diagnosis, management and long-term outcomes.

Authors:  Anudeepa Sharma; Ajuah Davis; Prem S Shekhawat
Journal:  Transl Pediatr       Date:  2017-10

2.  Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children.

Authors:  Katri Räikkönen; Mika Gissler; Eero Kajantie
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

Review 3.  The screening and management of newborns at risk for low blood glucose.

Authors:  Michael R Narvey; Seth D Marks
Journal:  Paediatr Child Health       Date:  2019-12-09       Impact factor: 2.253

4.  Neonatal Glycemia and Neurodevelopmental Outcomes at 2 Years.

Authors:  Christopher J D McKinlay; Jane M Alsweiler; Judith M Ansell; Nicola S Anstice; J Geoffrey Chase; Gregory D Gamble; Deborah L Harris; Robert J Jacobs; Yannan Jiang; Nabin Paudel; Matthew Signal; Benjamin Thompson; Trecia A Wouldes; Tzu-Ying Yu; Jane E Harding
Journal:  N Engl J Med       Date:  2015-10-15       Impact factor: 91.245

5.  Antenatal corticosteroids for the late preterm infant and agnotology.

Authors:  J W Kaempf; G Suresh
Journal:  J Perinatol       Date:  2017-12       Impact factor: 2.521

6.  Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years.

Authors:  Christopher J D McKinlay; Jane M Alsweiler; Nicola S Anstice; Nataliia Burakevych; Arijit Chakraborty; J Geoffrey Chase; Gregory D Gamble; Deborah L Harris; Robert J Jacobs; Yannan Jiang; Nabin Paudel; Ryan J San Diego; Benjamin Thompson; Trecia A Wouldes; Jane E Harding
Journal:  JAMA Pediatr       Date:  2017-10-01       Impact factor: 16.193

7.  Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center.

Authors:  Nevert Badreldin; Grace G Willert; Andrea A Henricks; Alan Peaceman; Leslie A Caldarelli; Lynn M Yee
Journal:  Am J Obstet Gynecol MFM       Date:  2019-12-17

8.  Gross Motor Outcomes of Children Born Prematurely in Northern Ontario and Followed by a Neonatal Follow-Up Programme.

Authors:  Roxanne Bélanger; Chantal Mayer-Crittenden; Michèle Minor-Corriveau; Manon Robillard
Journal:  Physiother Can       Date:  2018       Impact factor: 1.037

9.  Developmental Outcomes of Preterm Infants With Neonatal Hypoglycemia.

Authors:  Rachel H Goode; Mallikarjuna Rettiganti; Jingyun Li; Robert E Lyle; Leanne Whiteside-Mansell; Kathleen W Barrett; Patrick H Casey
Journal:  Pediatrics       Date:  2016-11-04       Impact factor: 7.124

10.  Outcome at 2 Years after Dextrose Gel Treatment for Neonatal Hypoglycemia: Follow-Up of a Randomized Trial.

Authors:  Deborah L Harris; Jane M Alsweiler; Judith M Ansell; Gregory D Gamble; Benjamin Thompson; Trecia A Wouldes; Tzu-Ying Yu; Jane E Harding
Journal:  J Pediatr       Date:  2015-11-21       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.